Cyprus Business Journal
SEE OTHER BRANDS

Following business and economy news from Cyprus

Cyprus Business Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cyprus Business Journal.

Press releases published on August 7, 2025

Portman Ridge Finance Corporation Announces Second Quarter 2025 Financial Results

Portman Ridge Finance Corporation Announces Second Quarter 2025 Financial Results

Completed Merger with Logan Ridge Finance Corporation Reports Net Investment Income of $4.6 Million, or $0.50 Per Share for the Second Quarter Announces Third Quarter 2025 Quarterly Base Distribution of $0.47 Per Share and Supplemental Distribution of $0. …

Commerce to Host Sell-side Analyst Q&A Session at Upcoming BigSummit

Commerce to Host Sell-side Analyst Q&A Session at Upcoming BigSummit

AUSTIN, Texas, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Commerce.com, Inc. (Nasdaq: CMRC) (formerly BigCommerce Holdings, Inc.), a provider of an open, intelligent ecosystem of technology solutions that empower businesses to unlock data potential and deliver …

Scientific Industries Completes Strategic Refocus and Secures Proceeds of $10 million to Accelerate Growth of Two Data-Driven Business Platforms; Divests Genie® Division to OHAUS Corporation’s affiliate Troemner, LLC

Scientific Industries Completes Strategic Refocus and Secures Proceeds of $10 million to Accelerate Growth of Two Data-Driven Business Platforms; Divests Genie® Division to OHAUS Corporation’s affiliate Troemner, LLC

Realign priorities - AI-powered platforms to accelerate innovation and market leadership Driving transformation in pharmacy automation with VIVID’s advanced solutions Advancing AI-powered biomanufacturing with SBI’s DOTS Platform BOHEMIA, N.Y., Aug. 07, …

Concentrix to Present at Upcoming Investor Conferences

Concentrix to Present at Upcoming Investor Conferences

NEWARK, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Concentrix Corporation (NASDAQ: CNXC), a global technology and services leader, today announced that members of its senior executive team will be participating in the following upcoming conferences: …

ARMOUR Residential REIT, Inc. Announces Closing of Public Offering of 18,500,000 Shares of Common Stock

ARMOUR Residential REIT, Inc. Announces Closing of Public Offering of 18,500,000 Shares of Common Stock

VERO BEACH, Florida, Aug. 07, 2025 (GLOBE NEWSWIRE) -- ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR-PRC) (“ARMOUR” or the “Company”) today announced that it has closed an underwritten public offering of 18,500,000 shares of its common stock for total …

Fox Factory Holding Corp. Reports Second Quarter Fiscal 2025 Financial Results

Fox Factory Holding Corp. Reports Second Quarter Fiscal 2025 Financial Results

DULUTH, Ga., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Fox Factory Holding Corp. (NASDAQ: FOXF) (“FOX” or the “Company”), a premium brand and a global leader in the design, engineering and manufacturing of performance-defining products and systems for customers …

Interpace Biosciences Announces Second Quarter 2025 Financial and Business Results

Interpace Biosciences Announces Second Quarter 2025 Financial and Business Results

  ● Q2 Revenue of $9.2 million   ● Q2 Cash Collections of $10.8 million   ● Q2 Thyroid test volume up 16% year-over-year to record levels   ● Q2 Thyroid revenue of $8.7M; up 25% year-over-year to record levels PARSIPPANY, NJ, Aug. 07, 2025 (GLOBE NEWSWIRE) …

The Joint Corp. Reports Second Quarter 2025 Financial Results

The Joint Corp. Reports Second Quarter 2025 Financial Results

- Refranchised 37 clinics; Franchises now represent 92% of the portfolio - - Acquired rights to the Northwest regional developer territory - SCOTTSDALE, Ariz., Aug. 07, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager, …

Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results

Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results

Phase 2b NAVIGATE clinical trial evaluating CD388 for the prevention of seasonal influenza met primary and all secondary efficacy endpoints for all dose groups End of Phase 2 meeting request submitted to the U.S. Food and Drug Administration (FDA) Closed …

IMAC Holdings Announces Research Collaboration with Vanderbilt University Medical Center to Advance Immuno-Oncology Biomarker Discovery

IMAC Holdings Announces Research Collaboration with Vanderbilt University Medical Center to Advance Immuno-Oncology Biomarker Discovery

Project will leverage Ignite Proteomics’ reverse-phase protein array (RPPA) platform to profile tumor-immune signaling in breast-cancer samples Golden, CO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Ignite Proteomics LLC, a subsidiary of IMAC Holdings, Inc. (OTCQB: …

Omada Health Reports Second Quarter 2025 Results

Omada Health Reports Second Quarter 2025 Results

Revenue of $61 million, up 49% 52% Member Growth and Significant Progress Toward Profitability SAN FRANCISCO, Aug. 07, 2025 (GLOBE NEWSWIRE) --  Omada Health, Inc. (Nasdaq: OMDA), the virtual between-visit healthcare provider, today reported financial …

The RealReal Announces Second Quarter 2025 Results

The RealReal Announces Second Quarter 2025 Results

Q2 2025 Revenue of $165 million, up 14% Year-Over-Year Q2 2025 Net Loss of $(11) million improved $5 million Year-Over-Year Q2 2025 Adjusted EBITDA of $6.8 million improved $8.6 million Year-Over-Year Record high quarterly Gross Merchandise Value and Total …

Texas Roadhouse, Inc. Announces Second Quarter 2025 Results

Texas Roadhouse, Inc. Announces Second Quarter 2025 Results

LOUISVILLE, Ky., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Texas Roadhouse, Inc. (NasdaqGS: TXRH), today announced financial results for the 13 and 26 weeks ended July 1, 2025. Financial Results Financial results for the 13 and 26 weeks ended July 1, 2025 and June …

Hims & Hers Health, Inc.: Please contact the Portnoy Law Firm to recover your losses. August 25, 2025 Deadline to file Lead Plaintiff Motion.

Hims & Hers Health, Inc.: Please contact the Portnoy Law Firm to recover your losses. August 25, 2025 Deadline to file Lead Plaintiff Motion.

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug. 07, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Hims …

Health Catalyst Reports Second Quarter 2025 Results

Health Catalyst Reports Second Quarter 2025 Results

SALT LAKE CITY, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended …

Progyny, Inc. Announces Second Quarter 2025 Results

Progyny, Inc. Announces Second Quarter 2025 Results

Reports Record Revenue of $332.9 Million, Reflecting 9.5% Growth Generates $55.5 Million in Quarterly Operating Cash Flow and Record $105.3 Million over the First Half of 2025 Raises Full Year Guidance to Reflect Continued Increase in Pacing of Member …

Dorchester Minerals, L.P. Announces Second Quarter Results

Dorchester Minerals, L.P. Announces Second Quarter Results

DALLAS, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Dorchester Minerals, L.P. (the “Partnership”) (NASDAQ-DMLP) announced today the Partnership’s net income for the quarter ended June 30, 2025 of $12,347,000, or $0.25 per common unit. A comparison of the Partnership …

Key Tronic Corporation Announces Fourth Quarter Reporting and Annual Meeting Date

Key Tronic Corporation Announces Fourth Quarter Reporting and Annual Meeting Date

SPOKANE VALLEY, Wash., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Key Tronic Corporation (Nasdaq: KTCC), announced today that it plans to report its results for the fourth quarter and full year ended of fiscal 2025 after market close on August 27, 2025. Key Tronic …

scPharmaceuticals Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update

scPharmaceuticals Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update

Generated net FUROSCIX® revenue of $16 million in the second quarter of 2025; up 99% over Q2 2024 Doses shipped to patients increased 45% over Q1 2025 and 117% over Q2 2024 Launch of FUROSCIX in chronic kidney disease Autoinjector remains on track for sNDA …

FISERV INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Fiserv, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - FI

FISERV INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Fiserv, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - FI

SAN DIEGO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions